MONTIRONI, Rodolfo
 Distribuzione geografica
Continente #
NA - Nord America 45.148
EU - Europa 21.285
AS - Asia 20.425
SA - Sud America 5.551
AF - Africa 936
Continente sconosciuto - Info sul continente non disponibili 56
OC - Oceania 21
AN - Antartide 1
Totale 93.423
Nazione #
US - Stati Uniti d'America 44.452
SG - Singapore 6.453
BR - Brasile 4.378
VN - Vietnam 4.302
RU - Federazione Russa 3.935
UA - Ucraina 3.873
CN - Cina 2.466
IT - Italia 2.240
IE - Irlanda 2.236
HK - Hong Kong 2.195
DE - Germania 2.061
TR - Turchia 2.004
SE - Svezia 1.808
DK - Danimarca 1.436
FR - Francia 1.355
FI - Finlandia 974
KR - Corea 809
GB - Regno Unito 775
IN - India 454
AR - Argentina 409
BD - Bangladesh 387
CI - Costa d'Avorio 326
MX - Messico 270
CA - Canada 267
ID - Indonesia 214
EC - Ecuador 200
IQ - Iraq 193
ZA - Sudafrica 192
CO - Colombia 168
JP - Giappone 124
MA - Marocco 117
PK - Pakistan 110
NL - Olanda 107
VE - Venezuela 104
PL - Polonia 94
UZ - Uzbekistan 94
PH - Filippine 86
PY - Paraguay 84
ES - Italia 73
CL - Cile 72
SA - Arabia Saudita 66
BE - Belgio 57
EG - Egitto 56
EU - Europa 52
PE - Perù 52
TN - Tunisia 52
TH - Thailandia 49
JO - Giordania 48
UY - Uruguay 46
AT - Austria 39
MY - Malesia 39
KE - Kenya 38
DZ - Algeria 37
NP - Nepal 32
BO - Bolivia 31
AE - Emirati Arabi Uniti 28
AZ - Azerbaigian 28
KZ - Kazakistan 28
RO - Romania 27
LB - Libano 25
DO - Repubblica Dominicana 24
EE - Estonia 24
HN - Honduras 24
ET - Etiopia 23
OM - Oman 23
CR - Costa Rica 22
IL - Israele 21
AL - Albania 20
KG - Kirghizistan 20
TW - Taiwan 20
BH - Bahrain 18
PA - Panama 17
PS - Palestinian Territory 17
AU - Australia 16
BY - Bielorussia 14
CH - Svizzera 14
GR - Grecia 14
RS - Serbia 14
SN - Senegal 14
NG - Nigeria 13
AO - Angola 12
JM - Giamaica 12
TT - Trinidad e Tobago 12
AM - Armenia 11
BG - Bulgaria 11
CZ - Repubblica Ceca 11
GT - Guatemala 11
NI - Nicaragua 11
LT - Lituania 10
HU - Ungheria 9
KW - Kuwait 9
LV - Lettonia 9
LY - Libia 9
MD - Moldavia 9
SY - Repubblica araba siriana 8
GA - Gabon 7
GE - Georgia 7
PT - Portogallo 7
SV - El Salvador 7
CG - Congo 6
Totale 93.287
Città #
Ashburn 7.042
Singapore 3.993
Jacksonville 3.930
Chandler 3.293
Fairfield 3.238
Dallas 2.284
Dublin 2.230
Hong Kong 2.129
Boardman 2.075
Des Moines 1.840
Wilmington 1.770
Woodbridge 1.432
Ho Chi Minh City 1.412
San Jose 1.344
Seattle 1.279
Houston 1.268
Cambridge 1.006
New York 974
Hanoi 966
The Dalles 945
Lawrence 906
Princeton 905
San Mateo 890
Lauterbourg 811
Moscow 601
Ann Arbor 600
Beijing 570
Milan 518
Hefei 466
San Diego 425
Centro 416
Los Angeles 408
São Paulo 364
Abidjan 326
Da Nang 220
Munich 199
Haiphong 191
Helsinki 182
London 179
Buffalo 175
Chicago 168
Rio de Janeiro 142
Pune 132
Orem 131
Council Bluffs 130
Miano 127
Santa Clara 116
Shanghai 110
Mexico City 104
Tokyo 100
Washington 95
Norwalk 94
Guangzhou 91
Tashkent 87
Wuhan 86
Belo Horizonte 85
Warsaw 84
Johannesburg 79
Guayaquil 78
Turku 78
Curitiba 77
Brasília 76
Redmond 75
Biên Hòa 74
Columbus 72
Izmir 72
Porto Alegre 71
Montreal 69
Baghdad 67
Brooklyn 65
Frankfurt am Main 65
Falls Church 62
Rome 62
Denver 61
Chennai 59
Hải Dương 58
Phoenix 58
Quito 55
Atlanta 54
Can Tho 53
Salvador 53
Brussels 52
Dhaka 51
Salt Lake City 50
Turin 50
Vancouver 50
Campinas 48
Marche 48
San Francisco 47
Kilburn 44
Thái Bình 44
Thái Nguyên 44
Amman 43
Elk Grove Village 43
Jakarta 43
Cape Town 41
Manchester 40
Santiago 40
Stockholm 39
Medellín 38
Totale 58.132
Nome #
Metabolic phenotype of bladder cancer 260
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 246
Mitogen-activated protein kinases and apoptosis in PIN. 231
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 228
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 226
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 225
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 217
Immunotherapy in genitourinary cancers: Where are we going? 208
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 203
Designing novel immunocombinations in metastatic renal cell carcinoma 201
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 198
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 198
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 194
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 192
2004 WHO classification of the renal tumors of the adults. 191
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 191
Predicting future cancer burden in the United States by artificial neural networks 190
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 189
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 185
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 184
Clinical performance and utility of a NNMT-based urine test for bladder cancer 181
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 181
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 178
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 178
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 176
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 176
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 174
Biomarkers of aggressiveness in genitourinary tumors with emphasis on kidney, bladder, and prostate cancer 173
Re: Umberto Leone Roberti Maggiore, Simone Ferrero, Massimo Candiani, et al. Bladder Endometriosis: A Systematic Review of Pathogenesis, Diagnosis, Treatment, Impact on Fertility, and Risk of Malignant Transformation. Eur Urol 2017;71:790–807 172
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 172
[International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens]. 169
Exploring the Spectrum of Kidney Ciliopathies 169
The Role of Artificial Intelligence in the Diagnosis and Prognosis of Renal Cell Tumors 169
Standardized mitotic counts in breast cancer evaluation of the method 168
Secondary neoplasms of the urinary system and male genital organs. 167
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 166
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 164
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 162
Adjuvant and neoadjuvant approaches for urothelial cancer: Updated indications and controversies 161
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 161
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 160
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 160
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 159
Primary B-cell lymphoblastic lymphoma of the testis 159
An update on investigational therapies that target STAT3 for the treatment of cancer 158
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 157
[Gene p53 mutation and prognosis in bladder tumors]. 157
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 157
[Gleason's grading of prostatic cancer: a current perspective]. 156
[Interstitial cystitis: minimal diagnostic criteria]. 156
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 156
Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy 156
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 156
Microbiome and cancers, with focus on genitourinary tumors 156
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 155
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 153
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 153
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer 153
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States 153
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 152
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 152
Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter 152
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 152
Active surveillance for low-risk prostate cancer. 151
Metabolic Alterations in Renal and Prostate Cancer 151
[Adrenal metastasis: clinical and pathological aspects]. 150
[Thin glomerular basement membrane disease]. 148
[The kidney in rheumatoid arthritis]. 147
Molecular characterization of testicular germ cell tumors using tissue microdissection 147
Bone targeting agents in patients with metastatic prostate cancer: State of the art 147
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 146
The role of obesity in renal cell carcinoma patients: Clinical-pathological implications 146
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 145
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 145
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 145
Adjuvant therapy in renal cell carcinoma: Is it the right strategy to inhibit VEGF? 145
Is There a Role for Immunotherapy in Prostate Cancer? 144
Diagnostic Criteria for Ductal Adenocarcinoma of the Prostate.Interobserver Variability among 20 Expert Uropathologists. 144
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 143
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 143
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 143
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 142
2009 update on the classification of renal epithelial tumors in adults 142
[Prostate biopsy: characteristics of the histological sample]. 142
[Quantitative microscopy in histopathology]. 141
An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer 141
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 140
2005 update on pathology of prostate biopsies with cancer 140
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 140
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 140
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 139
Genitourinary cancers: molecular determinants for personalized therapies 139
AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study 139
Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1 alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up 138
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 138
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 137
MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. 137
Karyometry in the early detection and chemoprevention of intraepithelial lesions. 137
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 137
Totale 16.429
Categoria #
all - tutte 454.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 454.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021552 0 0 0 0 0 0 0 0 0 0 0 552
2021/20226.617 613 1.540 134 320 93 550 203 432 470 537 384 1.341
2022/202311.081 1.115 779 603 969 804 2.572 11 655 2.823 51 418 281
2023/20246.089 1.231 164 343 995 1.045 1.154 112 111 20 94 56 764
2024/202512.564 1.093 1.123 629 339 395 468 1.044 555 3.724 936 952 1.306
2025/202632.514 1.464 2.440 2.549 3.692 2.662 2.149 5.798 3.635 3.193 2.810 655 1.467
Totale 94.125